NCT01382342View on ClinicalTrials.gov

The Effect of Rasagiline on Cognition in Parkinson's Disease

PHASE4CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions

Parkinson's Disease

Interventions

DRUG

Rasagiline

1 mg daily

DRUG

Placebo

1 mg daily

Trial Locations (1)

02906

Butler Hospital, Providence

Sponsors

Lead Sponsor

Brown University

All Listed Sponsors

collaborator

Teva Pharmaceuticals USA

INDUSTRY

lead

Brown University

OTHER